Acronyms
ACPE Advisory Committee on Poliomyelitis Eradication
AD Auto-disable syringe
AE Adverse event
AEFI Adverse event following immunization
AER Adverse event report
AFP Acute flaccid paralysis
AFR WHO African Region
AMR WHO Region of the Americas
ARDS Adult respiratory distress syndrome
aVDPV Ambiguous vaccine-derived poliovirus
BAG Biosafety Advisory Group
BSL Biological safety level
CDC US Centers for Disease Control and Prevention
CRF Case report form
cVDPV Circulating vaccine-derived poliovirus
DSMB Data safety monitoring board
DTP Diphtheria-tetanus-pertussis vaccine
EB Executive Board to the World Health Assembly
ELISA Enzyme-linked immunosorbent assay
EMR WHO Eastern Mediterranean Region
EPI Expanded Programme on Immunization
ERC WHO Research Ethics Review Committee
EUR WHO European Region
GAPIII Third edition of the Global Action Plan to minimize post eradication poliovirus facility-associated risk
GCC Global Commission for the Certification of the Eradication of Poliomyelitis
GCP Good clinical practice
GFIMS Global Framework for Immunization Monitoring and Surveillance
GIVS Global Immunization Vision and Strategy
GPEI Global Polio Eradication Initiative
GPLN Global Polio Laboratory Network
IB Investigator's brochure
ICC Interagency coordinating committee
ICST Inter-country support team
IEC Independent ethics committee
IHR (2005) International Health Regulations (2005)
IMB Independent Monitoring Board
IPV Inactivated poliovirus vaccine
IRB Institutional review board
ITD Intra-typic differentiation
IV Intra-venous
IVB WHO Department of Immunization, Vaccines and Biologicals
IVR Initiative for Vaccine Research
iVDPV Immunodeficiency-associated vaccine-derived poliovirus
mOPV1 Monovalent oral poliovirus vaccine type 1
mOPV2 Monovalent oral poliovirus vaccine type 2
mOPV3 Monovalent oral poliovirus vaccine type 3
NCC National Certification Committee
NCL National control laboratory
NID National Immunization Day
NPAFP Non-polio acute flaccid paralysis
NPEV Non-polio enterovirus
NPSP National Polio Surveillance Project ( India )
NRA National Regulatory Authority
NSL Non Sabin-like
OPV Oral poliovirus vaccine
PI Principal investigator
QA Quality assurance
QC Quality control
RCC Regional Certification Committee
SAE Severe (or serious) adverse event
SEAR WHO South- East Asia Region
SIA Supplementary Immunization Activity
sIPV Sabin IPV
SAGE Strategic Advisory Group of Experts on Immunization
SL Sabin-like
SNID Subnational Immunization Day
SOP Standard operating procedures
TAG Technical Advisory Group
tOPV Trivalent oral poliovirus vaccine
UN United Nations
UNDP United Nations Development Programme
UNICEF United Nations Children's Fund
UTI Urinary tract infection
VAPP Vaccine-associated paralytic polio
VDPV Vaccine-derived poliovirus
VPD Vaccine-preventable disease
WHA World Health Assembly
WHO World Health Organization
WPR WHO Western Pacific Region
WPV Wild poliovirus